Table 1. WHO 2016 Revised Diagnostic Criteria for chronic neutrophilic leukemia.
1. Peripheral blood WBC ≥25×109/L |
Segmented neutrophils plus band forms ≥80% of WBC |
Neutrophil precursors (promyelocytes, myelocytes, and metamyelocytes) <10% of WBC |
Myeloblasts rarely observed |
Monocyte count <1×109/L |
No dysgranulopoiesis |
2. Hypercellular bone marrow |
Neutrophil granulocytes increased in percentage and number |
Normal neutrophil maturation |
Myeloblasts <5% of nucleated cells |
3. Not meeting WHO criteria for BCR-ABL+ CML, PV, ET, or PMF |
4. No rearrangement of PDGFRA, PDGFRB, or FGFR1, or PCM1-JAK2 |
5. Presence of CSF3RT618I or other activating CSF3R mutation |
In the absence of a CSFR3R mutation, persistent neutrophilia (at least 3 months), splenomegaly, and no identifiable cause of reactive neutrophilia including absence of a plasma cell neoplasm or, if present, demonstration of clonality of myeloid cells by cytogenetic or molecular studies |
WHO: World Health Organization, WBC: white blood cells, CML: chronic myeloid leukemia, PV: polycythemia vera, ET: essential thrombocythemia, PMF: primary myelofibrosis.